Evidence map›Paper›PMID 30693176›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

Nanoscale Coatings for Ultralow Dose BMP-2-Driven Regeneration of Critical-Sized Bone Defects.

Zhe A Cheng, Andres Alba-Perez, Cristina Gonzalez-Garcia, Hannah Donnelly, Virginia Llopis-Hernandez, Vineetha Jayawarna, Peter Childs, David W Shields, Marco Cantini, Laura Ruiz-Cantu and 7 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Zhe A ChengCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
Andres Alba-PerezCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
Cristina Gonzalez-GarciaCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
Hannah DonnellyCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
Virginia Llopis-HernandezCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
Vineetha JayawarnaCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
Peter ChildsCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
David W ShieldsCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
Marco CantiniCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
Laura Ruiz-CantuCentre for Additive Manufacturing University of Nottingham Nottingham UK.
Andrew ReidCentre for Ultrasonic Engineering Department of Electronic and Electrical Engineering University of Strathclyde Glasgow UK.
James F C WindmillCentre for Ultrasonic Engineering Department of Electronic and Electrical Engineering University of Strathclyde Glasgow UK.
Elena S AddisonSmall Animal Hospital University of Glasgow Glasgow UK.
Sandra CorrSmall Animal Hospital University of Glasgow Glasgow UK.
William G MarshallSmall Animal Hospital University of Glasgow Glasgow UK.
Matthew J DalbyCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.
Manuel Salmeron-SanchezCentre for the Cellular Microenvironment University of Glasgow G12 8LT Glasgow UK.ORCID https://orcid.org/0000-0002-8112-2100
University of Glasgow · GBUniversity of Strathclyde · GBUniversity of Nottingham · GB

Funding

Biotechnology and Biological Sciences Research Council BB/G008868/1Biotechnology and Biological Sciences Research Council JF20604European Research Council 615030Medical Research Council MR/L022710/1
6 · The paper itself

Abstract

While new biomaterials for regenerative therapies are being reported in the literature, clinical translation is slow. Some existing regenerative approaches rely on high doses of growth factors, such as bone morphogenetic protein-2 (BMP-2) in bone regeneration, which can cause serious side effects. An ultralow-dose growth factor technology is described yielding high bioactivity based on a simple polymer, poly(ethyl acrylate) (PEA), and mechanisms to drive stem cell differentiation and bone regeneration in a critical-sized murine defect model with translation to a clinical veterinary setting are reported. This material-based technology triggers spontaneous fibronectin organization and stimulates growth factor signalling, enabling synergistic integrin and BMP-2 receptor activation in mesenchymal stem cells. To translate this technology, plasma-polymerized PEA is used on 2D and 3D substrates to enhance cell signalling in vitro, showing the complete healing of a critical-sized bone injury in mice in vivo. Efficacy is demonstrated in a Münsterländer dog with a nonhealing humerus fracture, establishing the clinical translation of advanced ultralow-dose growth factor treatment.

Indexed as

biomaterialsbone regenerationgrowth factor deliverystem cell differentiation

Identifiers

PMID30693176
PMCPMC6343071
OpenAlexW2901972748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.